211 related articles for article (PubMed ID: 38060238)
1. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
2. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
[TBL] [Abstract][Full Text] [Related]
3. Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone.
Stephens EM; Plonowska-Hirschfeld K; Gulati A; Kansara S; Qualliotine J; Zelbolsky AL; van Zante A; Ha PK; Heaton CM; Ryan WR
Am J Otolaryngol; 2023; 44(4):103915. PubMed ID: 37210888
[TBL] [Abstract][Full Text] [Related]
4. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.
Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C
Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795
[TBL] [Abstract][Full Text] [Related]
5. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
[TBL] [Abstract][Full Text] [Related]
6. Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.
Lee E; Gorelik D; Crowder HR; Badger C; Schottler J; Li NW; Siegel R; Sadeghi N; Goodman JF; Thakkar PG; Joshi AS
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):298-304. PubMed ID: 34752157
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma.
Yin X; Shan C; Wang J; Zhang H
Oral Oncol; 2020 Apr; 103():104590. PubMed ID: 32050152
[TBL] [Abstract][Full Text] [Related]
8. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
11. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract][Full Text] [Related]
13. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy.
Scott SI; Madsen AKØ; Rubek N; Charabi BW; Wessel I; Jensen CV; Friborg J; von Buchwald C
Laryngoscope; 2023 Aug; 133(8):1893-1898. PubMed ID: 36239625
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
[TBL] [Abstract][Full Text] [Related]
15. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.
Dziegielewski PT; Teknos TN; Durmus K; Old M; Agrawal A; Kakarala K; Marcinow A; Ozer E
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1099-108. PubMed ID: 23576186
[TBL] [Abstract][Full Text] [Related]
16. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
17. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
18. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
19. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
[TBL] [Abstract][Full Text] [Related]
20. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
